Skip to main content
Top
Published in: BMC Infectious Diseases 7/2014

Open Access 01-12-2014 | Poster presentation

Severe and prolonged febrile agranulocytosis under thyrosol

Authors: Mihaela Ionică, Roxana Geantă, Șerban Benea, Bogdana Manu, Alina Cozma, Mihai Olariu, Olga Dorobăț, Cleo Roşculeț, Ramona Zamfir, Adrian Miron, Elisabeta Benea

Published in: BMC Infectious Diseases | Special Issue 7/2014

Login to get access

Excerpt

It is well known that patients with severe neutropenia are susceptible to bacterial infections, which may become life-threatening. This hematologic disorder frequently occurs as an adverse effect of certain drug therapies. One of them, currently encountered in practice, is therapy with antithyroid drugs. An infective source is identified in average in 20-30% of febrile neutropenia episodes. Often the only infection proof is bacteremia, documented in 10-25% of patients. …
Metadata
Title
Severe and prolonged febrile agranulocytosis under thyrosol
Authors
Mihaela Ionică
Roxana Geantă
Șerban Benea
Bogdana Manu
Alina Cozma
Mihai Olariu
Olga Dorobăț
Cleo Roşculeț
Ramona Zamfir
Adrian Miron
Elisabeta Benea
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue Special Issue 7/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-S7-P96

Other articles of this Special Issue 7/2014

BMC Infectious Diseases 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine